Beskrivning
Land | Finland |
---|---|
Lista | First North Finland |
Sektor | Hälsovård |
Industri | Medicinteknik |
Managers' transactions, 10 June 2022 at 08:50 (EEST)
____________________________________________
Person subject to the notification requirement
Name: Soininen, Timo
Position: Member of the Board/Deputy member
Issuer: Nightingale Health Oyj
LEI: 743700WUIPC24LVMLO66
Notification type: INITIAL NOTIFICATION
Reference number: 16035/6/4
____________________________________________
Transaction date: 2022-06-08
Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)
Instrument type: SHARE
ISIN: FI4000490875
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 33 Unit price: 1.9900 EUR
(2): Volume: 1,952 Unit price: 1.9900 EUR
(3): Volume: 144 Unit price: 2.0000 EUR
(4): Volume: 2,000 Unit price: 1.9780 EUR
(5): Volume: 628 Unit price: 1.9700 EUR
(6): Volume: 3.000 Unit price: 1.9780 EUR
(7): Volume: 1,365 Unit price: 1.9760 EUR
(8): Volume: 2,611 Unit price: 1.9780 EUR
(9): Volume: 1,000 Unit price: 1.9780 EUR
(10): Volume: 368 Unit price: 1.9620 EUR
(11): Volume: 568 Unit price: 1.9780 EUR
(12): Volume: 552 Unit price: 1.9780 EUR
(13): Volume: 74 Unit price: 1.9500 EUR
(14): Volume: 45 Unit price: 1.9500 EUR
(15): Volume: 99 Unit price: 1.9500 EUR
(16): Volume: 13 Unit price: 1.9920 EUR
(17): Volume: 1,392 Unit price: 1.9920 EUR
(18): Volume: 198 Unit price: 1.9920 EUR
(19): Volume: 448 Unit price: 1.9650 EUR
(20): Volume: 421 Unit price: 2.000 EUR
(21): Volume: 322 Unit price: 1.9970 EUR
(22): Volume: 901 Unit price: 2.000 EUR
(23): Volume: 3,178 Unit price: 2.0300 EUR
(24): Volume: 564 Unit price: 2.0300 EUR
(25): Volume: 94 Unit price: 2.0300 EUR
(26): Volume: 438 Unit price: 2.0225 EUR
(27): Volume: 232 Unit price: 2.0350 EUR
(28): Volume: 541 Unit price: 2.0350 EUR
(29): Volume: 500 Unit price: 2.0350 EUR
(30): Volume: 739 Unit price: 2.0350 EUR
(31): Volume: 580 Unit price: 2.0350 EUR
Aggregated transactions
(31): Volume: 25,000 Volume weighted average price: 1.99503 EUR
For further information, please contact:
Teemu Suna, CEO
ir@nightingalehealth.com
Certified Adviser:
Oaklins Merasco Ltd. tel. +358 9 6129 670
About Nightingale Health
Nightingale Health is The Preventative Health Company. Staying healthy is one of the top priorities in human life. Our health has a profound impact on our quality of life, and it's also strongly connected to the lives of those close to us. Nightingale Health enables prevention by combining the power of our in-house developed, advanced blood analysis technology with unprecedented access to global health repositories and world-leading medical research. With this combination, we go beyond the traditional healthcare and wellbeing tools: We provide the scientific connection to multiple health and disease outcomes and the ability to predict future healthy years.